BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 27339445)

  • 1. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients.
    Takayama Y; Yasuda Y; Suzuki S; Shibata Y; Tatami Y; Shibata K; Niwa M; Sawai A; Morimoto R; Kato S; Ishii H; Maruyama S; Murohara T
    Heart Vessels; 2016 Jul; 31(7):1030-7. PubMed ID: 26164596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-Detected Growth of Coronary Artery Calcification in Asymptomatic Middle-Aged Subjects and Association With 15 Biomarkers.
    Diederichsen SZ; Grønhøj MH; Mickley H; Gerke O; Steffensen FH; Lambrechtsen J; Rønnow Sand NP; Rasmussen LM; Olsen MH; Diederichsen A
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):858-866. PubMed ID: 28797406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study.
    Bundy JD; Chen J; Yang W; Budoff M; Go AS; Grunwald JE; Kallem RR; Post WS; Reilly MP; Ricardo AC; Rosas SE; Zhang X; He J;
    Atherosclerosis; 2018 Apr; 271():53-60. PubMed ID: 29459266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
    Chaikriangkrai K; Nabi F; Mahmarian JJ; Chang SM
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1619-26. PubMed ID: 26243534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis.
    Lamprea-Montealegre JA; McClelland RL; Astor BC; Matsushita K; Shlipak M; de Boer IH; Szklo M
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):652-8. PubMed ID: 23329135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
    Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
    J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Artery Calcium Volume and Density: Potential Interactions and Overall Predictive Value: The Multi-Ethnic Study of Atherosclerosis.
    Criqui MH; Knox JB; Denenberg JO; Forbang NI; McClelland RL; Novotny TE; Sandfort V; Waalen J; Blaha MJ; Allison MA
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):845-854. PubMed ID: 28797404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
    Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
    J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.